Objective: To assess the prevalence of extended spectrum beta lactamase (ESBL) and metallo beta lactamase (MBL) producing Pseudomonas aeruginosa from pus samples.
INTRODUCTION
Multidrug-resistant Pseudomonas aeruginosa, a major pathogen in pyogenic infections (Soumya and Nagmoti 2017) are serious problems to the successful treatment of the wounds leading to complications sometime even fatal sepsis.
P. aeruginosa is intrinsically resistant to most of the drugs making the therapeutic choices limited for its treatment (Murray et al. 2015) . The acquisition of ESBL and MBL producing genes by P. aeruginosa has made the bacteria resistant to the antibiotics among the limited choice.
Thus, making the treatment of infections caused by P. aeruginosa diffi cult or impossible to treat and increasing global threat in community and hospital settings (Ansari et al. 2016; Hirsh and Tam 2010; Solomon et al. 2017 ).
ESBLs are plasmid-mediated beta-lactamase that confer resistance to the penicillins, fi rst-, second-, and third-generation cephalosporins, and Aztreonam and are inhibited by β-lactamase inhibitors such as clavulanic acid (Poudyal et al. 2011) . The exposure of bacterial strains to a multitude of beta-lactams has The ESBL and MBL producing P. aeruginosa infections have high mortality rates and have emerged worldwide rapidly. A very few study on ESBL and MBL producing P. aeruginosa has been conducted in Nepal thus necessitating the extensive study on its prevalence. This study was conducted with an objective toassess the prevalence of ESBL and MBL producing P. aeruginosa from pus samples.. This study would help to plan a proper hospital infection control strategy to prevent the spread of these isolates.
MATERIALS AND METHODS
A hospital based descriptive cross sectional study was 
ESBL detection
The isolates were screened for possible ESBL production using Ceftazidime (30μg) as per CLSI 2014 guidelines.
According to the guidelines, isolates showing cefpodoxime <17mm, ceftazidime<22mm, aztreonam ≤27mm, cefotaxime <27mm, and ceftriaxone<25mm are the possible ESBL producing strains. ESBL production was confi rmed among the suspected bacterial strain using combined disk (CD) assay, an increase in zone size of ≥5mm from either of the combination disk i.e. clavulanate containing disk indicated the presence of ESBL in the test organisms.
MBL detection
For the detection of production of MBL, combined disk test (CDT) was performed using two Imipenem disks (10μg), one containing 10μl of 0.1 M (292μg) anhydrous EDTA (Hi-Media, India). Disks were placed 25mm apart and an increase in zone diameter of > 4 mm around the IPM-EDTA disk compared to that of the IPM disk alone was considered positive for MBL production. These isolates were considered to be of the MBL positive phenotype (Lee et al. 2003) .
RESULTS
Among 316 non repetitive pus samples processed, P. aeruginosa was isolated from 25(7.9%) samples ( Figure   1 ). Maximum number of isolates were obtained from females 13(52%) and in the age group 4-5 years 8(32%).The association between culture positivity of P. aeruginosa isolates with age and gender was found statistically insignifi cant (p>0.05). Highest percentage of Pseudomonas aeruginosa isolates were sensitive to Polymyxin B (96%), followed by Imipenem (92%), Amikacin (88%) ( Table 1) .
Among 25 P. aeruginosa isolates, 9(36%) were ESBL producers and 2(8%) were MBL producers. Of 21 screening positive P. aeruginosa, 9(42.9%) were confi rmed to be ESBL producers by phenotypic methods. There was no association between screening and confi rmatory tests (p>0.05) ( Table 2) . ESBL producers were predominant in the age group 2-3 years (33.3%) (Table 3 ) and in male patient (55.6%) ( Table 4) . Out of 2 MBL producing P. aeruginosa 1(50%) was isolated from the age group below 2 years and male patient and 1(50%) from the age group 8-9 years and female patient. ESBL production and MBL production was found to be insignifi cantly associated with age and gender (p>0.05). Maximum number of isolates were obtained from the age group 4-5 years 8(32%). The study carried out by Hassuna et al. 2015 showed the higher isolation of P.
aeruginosa from the age group below 10 years. The association between culture positivity of P. aeruginosa isolates with age and gender was found statistically insignifi cant (p>0.05). This study showed the prevalence of MBL producing P. aeruginosa to be 8% which is high as compared to the study conducted in Nepal by Mishra et al. 2012 , Shrestha et al. 2011 Out of 2 MBL producing P. aeruginosa 1(50%) was isolated from the age group below 2 years and male patient and 1(50%) from the age group 8-9 years and female patient. MBL production was found to be insignifi cantly associated with age and gender (p>0.05).
Polymyxin B was found to be the most effective drug against P. aeruginosa with 96% susceptibility which is in accordance with the similar study carried out by Kumar et al. 2014 , Sharma et al. 2016 
CONCLUSION
This study showed the increased prevalence of ESBL and MBL production in P. aeruginosa which warrants early detection in routine laboratory, immediate infection control, and antibiotic stewardship programs in order to limit the spread of ESBL and MBL positive isolates. The appearance of ESBL and MBL genes and their spread among bacterial pathogens are matters of major concern with regard to the future antimicrobial chemotherapy. Polymyxin B was found to be the most effective drug against P. aeruginasa.
